Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Thyroid Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02515084
What this trial is testing

Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma

Who this might be right for
Thyroid CancerRelapse
Centre Henri Becquerel 37
Not applicableLooking for participantsNCT07328243
What this trial is testing

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

Who this might be right for
Thyroid Cancer PatientsLymph Node Metastasis
Tian'an Jiang 85
Not applicableNot Yet RecruitingNCT06426758
What this trial is testing

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Who this might be right for
Graves DiseaseGraves' Disease in RemissionEpstein-Barr Virus
Xiao-Ming Mao 300
Not applicableUnknownNCT04336696
What this trial is testing

Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?

Who this might be right for
Papillary Thyroid Carcinoma
Bassem Mohamed Sieda 199
Testing effectiveness (Phase 2)Study completedNCT01502410
What this trial is testing

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

Who this might be right for
Childhood Hepatocellular CarcinomaPapillary Thyroid CancerPreviously Treated Childhood Rhabdomyosarcoma+4 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)UnknownNCT00098852
What this trial is testing

Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT01057589
What this trial is testing

Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 66
Testing effectiveness (Phase 2)Study completedNCT01164176
What this trial is testing

Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 40
Not applicableWithdrawnNCT00373711
What this trial is testing

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

Who this might be right for
Thyroid Cancer
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00060242
What this trial is testing

Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07753499
What this trial is testing

Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer

Who this might be right for
TumorSolid TumorThyroid Cancer
The First Affiliated Hospital of Xiamen University 120
Testing effectiveness (Phase 2)Study completedNCT00118248
What this trial is testing

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Ended earlyNCT04985604
What this trial is testing

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorCRAF Gene Amplification+20 more
Day One Biopharmaceuticals, Inc. 23
Not applicableUnknownNCT06468696
What this trial is testing

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Who this might be right for
Papillary Thyroid CancerLymph Node MetastasisCarcinogenesis
Second Affiliated Hospital of Xi'an Jiaotong University 170
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Early research (Phase 1)Ended earlyNCT02313012
What this trial is testing

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Who this might be right for
Neoplasm Metastasis
Celgene 19
Next Page